The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2

Cell Cycle

Volumn 14, Issue 16, 2015, Pages 2688-2700

  Jamal, Azfar ^a   Swarnalatha, Manickavinayaham ^a   Sultana, Sarwat ^b   Joshi, Prashant ^c   Panda, Subrat K ^c   Kumar, Vijay ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b HAMDARD UNIVERSITY   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

c Myc; Cell cycle; E3 ubiquitin ligase; HBx; Skp2; TRUSS; Ubiquitination

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; MYC PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED UBIQUITOUS SCAFFOLDING AND SIGNALING PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; MYC PROTEIN, HUMAN; PROTEIN BINDING; S PHASE KINASE ASSOCIATED PROTEIN; TRANSACTIVATOR PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPC4AP PROTEIN, HUMAN;

ARTICLE; CANCER CELL LINE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; DELETION MUTANT; DOWN REGULATION; EMBRYO; GENE EXPRESSION; HALF LIFE TIME; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MICROENVIRONMENT; NEOPLASM; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; UBIQUITINATION; VIRUS GENOME; BREAST TUMOR; COLON TUMOR; ENZYME STABILITY; ENZYMOLOGY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HEK293 CELL LINE; HEP-G2 CELL LINE; LIVER TUMOR; METABOLISM; PANCREAS TUMOR; PHOSPHORYLATION; PHYSIOLOGY;

BREAST NEOPLASMS; COLONIC NEOPLASMS; ENZYME STABILITY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANS-ACTIVATORS; TRPC CATION CHANNELS; UBIQUITINATION;

EID: 84943787999     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1056946     Document Type: Article

References (48)

1. Schwartz AL, Ciechanover A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 2009; 49: 73-96; PMID: 18834306; http://dx. doi. org/10. 1146/annurev. pharmtox. 051208. 165340.
2. Nakayama KI, Nakayama K. Ubiquitin ligases: cellcycle control and cancer. Nat Rev Cancer 2006; 6: 369-81; PMID: 16633365; http://dx. doi. org/10. 1038/nrc1881.
3. Kitagawa K, Kotake Y, Kitagawa M. Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci 2009; 100: 1374-81; PMID: 19459846; http://dx. doi. org/10. 1111/j. 1349-7006. 2009. 01196. x.
4. Frescas D, Pagano M. Deregulated proteolysis by the Fbox proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 2008; 8: 438-49; PMID: 18500245; http://dx. doi. org/10. 1038/nrc2396.
5. WelckerM, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8: 83-93; PMID: 18094723; http://dx. doi. org/10. 1038/nrc2290.
6. Lee J, Zhou P. DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol Cell 2007; 26: 775-80; PMID: 17588513.
7. Jackson S, Xiong Y. CRL4s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem Sci 2009; 34: 562-70; PMID: 19818632; http://dx. doi. org/10. 1016/j. tibs. 2009. 07. 002.
8. Sugasawa K, Okuda Y, Saijo M, Nishi R, Matsuda N, Chu G, Mori T, Iwai S, Tanaka K, Tanaka K, et al. UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell 2005; 121: 387-00; PMID: 15882621; http://dx. doi. org/10. 1016/j. cell. 2005. 02. 035.
9. Nag A, Bondar T, Shiv S, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells. Mol Cell Biol 2001; 21: 6738-47; PMID: 11564859; http://dx. doi. org/10. 1128/MCB. 21. 20. 6738-6747. 2001.
10. Wang H, Zhai L, Xu J, Joo HY, Jackson S, Erdjument-Bromage H, Tempst P, Xiong Y, Zhang Y. Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol Cell 2006; 22: 383-94; PMID: 16678110; http://dx. doi. org/10. 1016/j. molcel. 2006. 03. 035.
11. Kapetanaki MG, Guerrero-Santoro J, Bisi DC, Hsieh CL, Rapić-Otrin V, Levine AS. The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites. Proc Natl Acad Sci U SA 2006; 103: 2588-93; PMID: 16473935; http://dx. doi. org/10. 1073/pnas. 0511160103.
12. Choi SH, Wright JB, Gerber SA, Cole MD. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev 2010; 24: 1236-41; PMID: 20551172; http://dx. doi. org/10. 1101/gad. 1920310.
13. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18: 3004-16; PMID: 10378696; http://dx. doi. org/10. 1038/sj. onc. 1202746.
14. Vita M, Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 2006; 16: 318-30; PMID: 16934487; http://dx. doi. org/10. 1016/j. semcancer. 2006. 07. 015.
15. Andrejeva J, Poole E, Young DF, Goodbourn S, Randall RE. The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J Virol 2002; 76: 11379-86; PMID: 12388698; http://dx. doi. org/10. 1128/JVI. 76. 22. 11379-11386. 2002.
16. Ulane CM, Horvath CM. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 2002; 304: 160-66; PMID: 12504558; http://dx. doi. org/10. 1006/viro. 2002. 1773.
17. Ulane CM, Rodriguez JJ, Parisien JP, Horvath CM. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol 2003; 77: 6385-93; PMID: 12743296; http://dx. doi. org/10. 1128/JVI. 77. 11. 6385-6393. 2003.
18. Leupin O, Bontron S, Strubin M. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol 2005; 79: 4238-45; PMID: 15767425; http://dx. doi. org/10. 1128/JVI. 79. 7. 4238-4245. 2005.
19. Leupin O, Bontron S, Strubin M. Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities. J Virol 2003; 77: 6274-83; PMID: 12743284; http://dx. doi. org/10. 1128/JVI. 77. 11. 6274-6283. 2003.
20. Kalra N, Kumar V. The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc. FEBS Lett 2006; 580: 431-36; PMID: 16376880; http://dx. doi. org/10. 1016/j. febslet. 2005. 12. 034.
21. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Control of the SCF (Skp2-Cks1) ubiquitin ligase by the APC/C (Cdh1) ubiquitin ligase. Nature 2004; 11: 190-93; PMID: 15014502; http://dx. doi. org/10. 1038/nature02330.
22. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23: 2116-25; PMID: 15103331; http://dx. doi. org/10. 1038/sj. emboj. 7600217.
23. Cardozo T, Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 2004; 5: 739-51; PMID: 15340381; http://dx. doi. org/10. 1038/nrm1471.
24. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 2003; 11: 1189-00; PMID: 12769844; http://dx. doi. org/10. 1016/S1097-2765(03)00193-X.
25. Carrano AC, Eytan E, Hershko A, Pagano M. Skp2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1: 193-99; PMID: 10559916; http://dx. doi. org/10. 1038/12013.
26. Tedesco D, Lukas J, Reed SI. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev 2002; 16: 2946-57; PMID: 12435635; http://dx. doi. org/10. 1101/gad. 1011202.
27. Bornstein G, Bloom J, Sitry-Shevah D, Nakayama K, Pagano M, Hershko A. Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 2003; 278: 25752-57; PMID: 12730199; http://dx. doi. org/10. 1074/jbc. M301774200.
28. Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Nakayama KI. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci U SA 2003; 100: 10231-36; PMID: 12925736; http://dx. doi. org/10. 1073/pnas. 1831009100.
29. Mendez J, Zou-Yang XH, Kim SY, Hidaka M, Stillman B. Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Mol Cell 2002; 9: 481-91; PMID: 11931757; http://dx. doi. org/10. 1016/S1097-2765(02)00467-7.
30. Li X, Zhao Q, Liao R, Sun P, Wu X. The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. J Bio Chem 2003; 278: 30854-58; PMID: 12840033; http://dx. doi. org/10. 1074/jbc. C300251200.
31. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Hatakeyama S. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19: 2069-81; PMID: 10790373; http://dx. doi. org/10. 1093/emboj/19. 9. 2069.
32. Marti A, Wirbelauer C, Scheffner M, Krek W. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1999; 1: 14-19; PMID: 10559858; http://dx. doi. org/10. 1038/8984.
33. Tsai YS, Lai CL, Lai CH, Chang KH, Wu K, Tseng SF, Fazli L, Gleave M, Xiao G, Gandee L, et al. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth. Oncotarget 2014; 5: 6425-36; PMID: 25115390.
34. Lu W, Liu S, Li B, Xie Y, Adhiambo C, Yang Q, Ballard BR, Nakayama KI, Matusik RJ, Chen Z. SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination. Oncotarget 2015; 6: 771-88; PMID: 25596733.
35. Wertz IE, O'Rourke KM, Zhang Z, Dornan D, Arnott D, Deshaies RJ, Dixit VM. Human de-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science 2004; 303: 1371-74; PMID: 14739464; http://dx. doi. org/10. 1126/science. 1093549.
36. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75: 495-05; PMID: 8221889; http://dx. doi. org/10. 1016/0092-8674(93)90384-3.
37. Harty RN, Brown ME, McGettigan JP, Wang G, Jayakar HR, Huibregtse JM, Whitt MA, Schnell MJ. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol 2011; 75: 10623-29; PMID: 11602704; http://dx. doi. org/10. 1128/JVI. 75. 22. 10623-10629. 2001.
38. Winberg G, Matskova L, Chen F, Plant P, Rotin D, Pawson T. Latent Membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol Cell Biol 2002; 20: 8526-35; PMID: 11046148; http://dx. doi. org/10. 1128/MCB. 20. 22. 8526-8535. 2000.
39. Coscoy L, Sanchez DJ, Ganem D. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J Cell Biol 2001; 155: 1265-73; PMID: 11756476; http://dx. doi. org/10. 1083/jcb. 200111010.
40. Bour S, Perrin C, Akari H, Strebel K. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCPmediated degradation of Ikappa B. J Biol Chem 2001; 276: 15920-28; PMID: 11278695; http://dx. doi. org/10. 1074/jbc. M010533200.
41. Kumar V, Sarkar DP. Hepatitis B virus X protein (HBx): structure-function relationship and role in viral pathogenesis. in: Handbook of Experimental Pharmacology. Triezenberg SJ, Kaufman J, Gossen M, Eds., Germany: Springer-Verlag; 2004, pp. 377-407.
42. SirmaH, Weil R, RosmorducO, UrbanS, Israel A, Brechot C. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene 1998; 16: 2051-63; PMID: 9572486; http://dx. doi. org/10. 1038/sj. onc. 1201737.
43. Shukla SK, Kumar V. HBx and c-myc cooperate in the up-regulation of ribosome biogenesis and in cellular transformation. FEBS J 2012; 279: 3859-71; PMID: 22889122; http://dx. doi. org/10. 1111/j. 1742-4658. 2012. 08745. x.
44. Kumar V, Jayasuryan N, Kumar R. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci U S A 1996; 93: 5647-52; PMID: 8643631; http://dx. doi. org/10. 1073/pnas. 93. 11. 5647.
45. Huang X, Summers MK, Pham V, Lill JR, Liu J, Lee G, Kirkpatrick DS, Jackson PK, Fang G, Dixit VM. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. Mol Cell 2011; 20: 511-23; PMID: 21596315; http://dx. doi. org/10. 1016/j. molcel. 2011. 03. 027.
46. Liao TL, Wu CY, Su WC, Jeng KS, Lai MM. Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J 2010; 29: 3879-90; PMID: 20924359; http://dx. doi. org/10. 1038/emboj. 2010. 250.
47. Kumar V, Jayasuryan N, Reddi H, Sahal D, Panda SK. A monoclonal antibody against the X protein of hepatitis B virus: fine mapping of its epitope and application in a quantitative ELISA of the X protein in sera of hepatitis B patients. Hybridoma 1998; 17: 157-64; PMID: 9627056; http://dx. doi. org/10. 1089/hyb. 1998. 17. 157.
48. Janbandhu VC, Singh AK, Mukherji A, Kumar V. p65 negatively regulate transcription of the cyclin E gene. J Biol Chem 2010; 285: 17453-64; PMID: 20385564; http://dx. doi. org/10. 1074/jbc. M109. 058974.